Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STARD13 antisense RNA 2 (non-protein coding) (STARD13-AS2)
- Target
- STARD13-AS2
- Molecular classification
- Other (Long non-coding RNA or lncRNA)
01
Overview
STARD13 antisense RNA 2 (STARD13-AS2), also known as STARD13-AS, is a long non-coding RNA transcribed in the antisense direction relative to the STARD13 protein-coding gene. Unlike the STARD13 protein, which is a validated Rho GTPase-activating protein and tumor suppressor[1][2][3][4][5], the functional and disease-related significance of its antisense transcript remains largely uncharacterized. No evidence supports use of STARD13-AS2 as a receptor, enzyme, transporter, or a clinically relevant therapeutic target in its own right. Most research and databases focus on the protein-coding STARD13 gene, not the antisense non-coding RNA.
- Other names
- STARD13-ASSTARD13-AS2STARD13 antisense RNA 2 (non-protein coding)
02
Biological functions
Other (Insufficient data for specific functions; in general, antisense long non-coding RNAs may impact transcriptional regulation of the sense gene, but this role is not well characterized for STARD13-AS2 specifically.)
03
Disease associations
Other (No established direct disease roles for STARD13-AS2; known disease relevance is for STARD13 protein, particularly in cancer.)
Beyond the preview
Go deeper on STARD13 antisense RNA 2 (non-protein coding) (STARD13-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STARD13 antisense RNA 2 (non-protein coding) (STARD13-AS2).